Related Experiment Videos

Structure-activity studies of aplysiatoxin-type tumor promoters

Princess Takamatsu Symposia
|January 1, 1983
PubMed

Insights

Aplysiatoxin and related compounds exhibit tumor-promoting activity by binding to the phorboid receptor, similar to TPA. Specific hydroxyl groups are crucial for this activity, influencing cellular responses and tumor promotion.

Area of Science:

  • Marine natural products chemistry
  • Chemical biology
  • Toxicology

Background:

  • Aplysiatoxin, 12-O-tetradecanoylphorbol-13-acetate (TPA), teleocidin B, and lyngbyatoxin A share similar cellular activities.
  • These compounds, despite structural differences, bind to the phorboid receptor, mediating comparable biological effects.

Purpose of the Study:

  • To evaluate the tumor-promoting potential of aplysiatoxin-type compounds.
  • To identify structural features essential for the biological activity of aplysiatoxin.

Main Methods:

  • In vitro and in vivo assays for tumor promotion, including mouse ear irritation and ornithine decarboxylase (ODC) induction.
  • Inhibition of [3H]-TPA binding to epidermal fractions.
  • Long-term (30-week) two-step carcinogenesis experiments in mice.

Main Results:

  • Aplysiatoxin-type compounds demonstrated tumor-promoting activity across multiple test systems.
  • Results from preliminary tests correlated well with the long-term carcinogenesis experiment.
  • Hydroxyl groups at positions C-3, C-20, and C-30 were identified as essential for maximal activity.

Conclusions:

  • Aplysiatoxin and its analogs possess significant tumor-promoting capabilities.
  • Structural analysis suggests a specific alignment of oxygen atoms is critical for receptor binding and activity, analogous to TPA.
  • The findings provide insights into the structure-activity relationships of phorboid receptor ligands.

Related Concept Videos